Isofol Medical

0.67 SEK

-0.74%

Less than 1K followers

ISOFOL

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Isofol Medical

EV/S

Median 2020-2023

EV/EBIT

Median 2019-2025

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)10.0819.458.120.650.641.950.73
Shares64.5120.0183.8183.8183.8183.8281.1
Market cap650.22,334.21,492.4119.5117.9358.6204.9
Enterprise value526.02,219.31,114.6-68.6-20.2265.477.9
EV/S-59.849.7neg.neg.--
EV/EBITDAneg.neg.neg.0.40.5neg.neg.
EV/EBITneg.neg.neg.0.40.5neg.neg.
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B6.2035.074.690.750.974.601.90
P/S-62.966.69.3163.8--
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio71.6 %44.9 %79.3 %74.2 %86.4 %79.2 %83.4 %
Gearing ratio2.6 %2.2 %0.5 %1.5 %---